GC/EVP, Leg Affairs of Seattle Genetics Inc (30-Year Financial, Insider Trades) Jean I Liu (insider trades) sold 9,877 shares of SGEN on 06/19/2020 at an average price of $165 a share. The total sale was $1.6 million.
Seattle Genetics Inc is a biotechnology company. The company is focused on development and commercialization of targeted therapies for the treatment of cancer. Its products are ADCETRIS (brentuximab vedotin) US and ADCETRIS (brentuximab vedotin) Canada. Seattle Genetics Inc has a market cap of $29.59 billion; its shares were traded at around $170.92 with and P/S ratio of 30.15. GuruFocus has detected 2 severe warning signs with Seattle Genetics Inc. .
CEO Recent Trades:
- President and CEO Clay B Siegall sold 28,472 shares of SGEN stock on 06/08/2020 at the average price of $148.77. The price of the stock has increased by 14.89% since.
Directors and Officers Recent Trades:
- GC/EVP, Leg Affairs Jean I Liu sold 9,877 shares of SGEN stock on 06/19/2020 at the average price of $165. The price of the stock has increased by 3.59% since.
- Chief Medical Officer Roger D Dansey sold 2,162 shares of SGEN stock on 06/17/2020 at the average price of $158.89. The price of the stock has increased by 7.57% since.
- Chief Medical Officer Roger D Dansey sold 5,822 shares of SGEN stock on 06/16/2020 at the average price of $157.15. The price of the stock has increased by 8.76% since.
For the complete insider trading history of SGEN, click here
.
